Collaboration Product Royalties. In further consideration of the rights and licences granted to Orchard hereunder, in respect of all Collaboration Products generated using Collaboration Particles:
Collaboration Product Royalties. In consideration of the rights granted hereunder, subject to Section 6.6.2, Warner shall pay the following royalties to GenVec with respect to aggregate Net Sales of Collaboration Products in the Territory, on a Collaboration Product-by- Collaboration Product basis: Annual Net Sales up to * Annual Net Sales over * Notwithstanding the foregoing provisions of this Section 6.5.1, in the event that, with respect to a particular Collaboration Product (i) all Valid Claims owned or Controlled by GenVec cease to exist; and (ii) a Third Party who is not a Sublicensee commercializes a competing generic product which is identical to such Collaboration Product; and (iii) Warner believes that sales of such Collaboration Product would be commercially impracticable, Warner may notify GenVec and in such event, the parties shall discuss in good faith a reduction in the royalties payable under this Section 6.5.l; provided, however, that nothing contained herein shall obligate GenVec to agree to such reduction in royalties hereunder and the terms of this Agreement shall remain in full force and effect unless the Parties otherwise agree in writing.
Collaboration Product Royalties. In consideration of the rights granted hereunder, Warner shall pay the following royalties to Sequana with respect to annual aggregate Net Sales of Collaboration Products, on a Collaboration Product-by-Collaboration Product basis: [ * ] [ * ] [ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
Collaboration Product Royalties. Subject to the terms of this Section 6.3 [**], on a [**] basis, (a) BMS shall pay Immatics royalties on [**] BMS Product Net Sales of each BMS Product [**] during the applicable BMS Royalty Term for such BMS Product (provided that the [**]), and (b) Immatics shall pay BMS royalties on [**] Immatics Product Net Sales of each Immatics Product [**] during the applicable Immatics Royalty Term for such Immatics Product (provided that the [**]), in each case of (a) and (b), equal to the following portions of [**] Product Net Sales of the applicable Collaboration Product [**] multiplied by the applicable royalty rate set forth below for such portion of [**] Product Net Sales during the applicable BMS Royalty Term or Immatics Royalty Term, which royalties shall be paid in accordance with Section 6.3.6. For clarity, [**]. [**] BMS Product Net Sales of [**] Royalty Rate [**] [**] [**] [**] [**] [**] [**] BMS Product Net Sales of [**] Royalty Rate [**] [**] [**] [**] [**] [**] [**] Immatics Product Net Sales of [**] Royalty Rate [**] [**] [**] [**] Certain confidential information contained in this document, marked by [**], has been omitted because Immatics N.V. (the “Company”) has determined that the information (i) is not material and (ii) is customarily and actually treated by the Company as private or confidential. [**] Immatics Product Net Sales of [**] Royalty Rate [**] [**] The applicable royalty rates set forth in the applicable table above will apply only to that portion of the [**] Product Net Sales of the applicable Collaboration Product during a given [**] that falls within the indicated range. For clarity, [**]. In addition, the Parties hereby agree and acknowledge (on behalf of themselves and their respective Affiliates), notwithstanding anything to the contrary contained in the 2019 Agreements, no royalties shall be payable by BMS or any of its Affiliates under any of the 2019 Agreements with respect to any BMS TCR Product (and the sales of any BMS TCR Product shall not count for purposes of calculating any royalty tiers under any 2019 Agreement), and BMS shall only be responsible for payment of royalties on a BMS TCR Product pursuant to this Agreement.
Collaboration Product Royalties. In consideration of the rights ------------------------------- granted hereunder, subject to Section 6.6.2, Warner shall pay the following royalties to GenVec with respect to aggregate Net Sales of Collaboration Products in the Territory, on a Collaboration Product-by-Collaboration Product basis: [*] [*] [*] CERTAIN INFORMATION ON THIS PAGE HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. -25- [*]
